ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2000

Interleukin-1β, Oxidative Stress and Basic Calcium Phosphate Crystals Induce Osteoarthritis-like Changes in Chondrocyte Phenotype By Altering the Expression of PERIOD2, a Core Component of the Chondrocyte Circadian Clock

Jing Rong1, Mark Zhu2, Jacob Munro3, Geraldine M. McCarthy4, Jillian Cornish5, Nicola Dalbeth1 and Raewyn Poulsen2, 1University of Auckland, Auckland, New Zealand, 2Medicine, University of Auckland, Auckland, New Zealand, 3Orthopaedics, Auckland City Hospital, Auckland, New Zealand, 4Mater Misericordiae University Hospital, Dublin, Ireland, 5Department of Medicine, University of Auckland, Auckland, New Zealand

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: cell biology, Cell Signaling, chondrocytes and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Almost all cells contain a circadian clock. Cell clocks are key regulators of cell activity and cell differentiation. In osteoarthritis (OA), chondrocytes inappropriately undergo terminal differentiation leading to increased production of cartilage degrading enzymes. Recently, we found expression of two core circadian clock components, PER2 and BMAL1, is altered in chondrocytes in OA. In vitro and in vivo evidence indicates altered BMAL1 expression contributes to OA pathology. The purpose of this study was to determine potential causes of the altered PER2 and BMAL1 expression in OA, and to investigate the role of PER2 in regulating chondrocyte behaviour.

Methods: Chondrocytes were isolated from macroscopically normal (MN) and OA cartilage from 12 patients with OA. MN chondrocytes were treated with interleukin-1β (IL-1β, 10ng/ml), hydrogen peroxide (100µM) or basic calcium phosphate (BCP) crystals (50µg/ml) (stimuli previously shown to induce OA-associated changes in chondrocyte phenotype) for up to 48h. Clock gene expression was measured by RT-qPCR. RNAi was used to knockdown PER2 and chondrocyte phenotypic marker expression was assessed using RT-qPCR and ELISA.

Results: Consistent with previous findings, peak expression of BMAL1 was lower and peak expression of PER2 higher in OA compared to MN chondrocytes. In IL-1β, peroxide or BCP crystal-exposed MN chondrocytes, peak expression of BMAL1 was also lower, and PER2 levels remained elevated for longer, compared to untreated cells. IL-1β, peroxide and BCP-induced changes in disease-associated phenotypic markers (SOX9, ADAMTS5, MMP13) were partially mitigated by knockdown of PER2. PER2 knockdown in OA chondrocytes was associated with restoration of phenotypic marker expression to levels more similar to the non-diseased state. Notably, both RNA and protein levels of MMP13, the major enzyme implicated in the cartilage loss in OA, were reduced following PER2 knockdown in OA chondrocytes.

Conclusion: IL-1β, peroxide and BCP crystals induce similar changes in the expression of PER2 and BMAL1 as occur in OA. Increased PER2 expression contributes to the induction of OA-associated changes in chondrocyte phenotype following IL-1β, peroxide and BCP crystal treatment and contributes to the maintenance of the diseased phenotype in OA chondrocytes. Altered expression of PER2 and BMAL1 may be a central mechanism by which multiple different risk factors for OA induce disease-associated changes in chondrocyte activity.


Disclosure: J. Rong, None; M. Zhu, None; J. Munro, None; G. M. McCarthy, None; J. Cornish, None; N. Dalbeth, Horizon, 5,Kowa, 5,Amgen Inc., 2,AstraZeneca/Ironwood, 2,AbbVie Inc., 8,Pfizer, Inc., 8,Janssen, 8; R. Poulsen, Research grants from the Health Research Council of NZ and Arthritis, NZ, 2.

To cite this abstract in AMA style:

Rong J, Zhu M, Munro J, McCarthy GM, Cornish J, Dalbeth N, Poulsen R. Interleukin-1β, Oxidative Stress and Basic Calcium Phosphate Crystals Induce Osteoarthritis-like Changes in Chondrocyte Phenotype By Altering the Expression of PERIOD2, a Core Component of the Chondrocyte Circadian Clock [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/interleukin-1%ce%b2-oxidative-stress-and-basic-calcium-phosphate-crystals-induce-osteoarthritis-like-changes-in-chondrocyte-phenotype-by-altering-the-expression-of-period2-a-core-component-of-the-ch/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interleukin-1%ce%b2-oxidative-stress-and-basic-calcium-phosphate-crystals-induce-osteoarthritis-like-changes-in-chondrocyte-phenotype-by-altering-the-expression-of-period2-a-core-component-of-the-ch/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology